The NIH will be updating application instructions by November 25th to reflect changes in their appendix policy for applications due on or after January 25, 2017. The only allowable appendix materials (unless specified in the FOA) will be:
For applications proposing clinical trials
Clinical trial protocols
Investigator's brochure from Investigational New Drug (IND), as appropriate
For all applications
Blank informed consent/assent forms
Blank surveys, questionnaires, data collection instruments
FOA-specified items
Note that the biggest change is the disallowance of any publications.
No comments:
Post a Comment